MVCAX
Price
$30.04
Change
-$0.44 (-1.44%)
Updated
Jun 13 closing price
Net Assets
16.57B
SMVZX
Price
$11.93
Change
-$0.17 (-1.40%)
Updated
Jun 13 closing price
Net Assets
1.51B
Interact to see
Advertisement

MVCAX vs SMVZX

Header iconMVCAX vs SMVZX Comparison
Open Charts MVCAX vs SMVZXBanner chart's image
MFS Mid Cap Value A
Price$30.04
Change-$0.44 (-1.44%)
VolumeN/A
Net Assets16.57B
Virtus Ceredex Mid-Cap Value Equity R6
Price$11.93
Change-$0.17 (-1.40%)
VolumeN/A
Net Assets1.51B
MVCAX vs SMVZX Comparison Chart
Loading...
View a ticker or compare two or three
VS
MVCAX vs. SMVZX commentary
Jun 16, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MVCAX is a Buy and SMVZX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
MVCAX has more cash in the bank: 16.6B vs. SMVZX (1.51B). SMVZX pays higher dividends than MVCAX: SMVZX (1.27) vs MVCAX (0.89). MVCAX was incepted earlier than SMVZX: MVCAX (24 years) vs SMVZX (11 years). MVCAX (1.00) is less costly to investors than SMVZX (0.88). SMVZX is a more actively managed with annual turnover of: 141.00 vs. MVCAX (27.00). MVCAX has a lower initial minimum investment than SMVZX: MVCAX (1000) vs SMVZX (2500000). SMVZX (-4.38) and MVCAX (-4.53) have marching annual gain over last year. MVCAX return over 5 years is better than : 51.98 vs. SMVZX (23.76).
MVCAXSMVZXMVCAX / SMVZX
Total Expense Ratio0.990.79125%
Annual Report Gross Expense Ratio1.000.88114%
Fund Existence24 years11 years-
Gain YTD-2.086-1.160180%
Front Load6%N/A-
Min. Initial Investment100025000000%
Min. Initial Investment IRAN/AN/A-
Net Assets16.6B1.51B1,099%
Annual Yield % from dividends0.891.2770%
Returns for 1 year-4.53-4.38103%
Returns for 3 years13.0015.2985%
Returns for 5 years51.9823.76219%
Returns for 10 years53.51-4.56-1,173%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ELEV0.38N/A
+0.39%
Elevation Oncology
ICLR145.66-1.43
-0.97%
ICON plc
AKBA3.56-0.09
-2.47%
Akebia Therapeutics
AEIS122.80-3.88
-3.06%
Advanced Energy Industries
SLN5.33-0.26
-4.57%
Silence Therapeutics Plc